The U.S. Consumer Product Safety Commission (CPSC) announced a new rule on September 18, 2024, which will implement the first-ever…
Read More →
Building a safer digital future for all.…
Read More →
The Justice Department’s Antitrust Division has been aggressively pursuing civil enforcement actions. While criminal enforcement of antitrust laws has been…
Read More →
Summary The Federal Bureau of Investigation (FBI), the Cybersecurity and Infrastructure Security Agency (CISA), the National Security Agency (NSA), the…
Read More →
The United States Department of Defense (DoD) finalized a new rule implementing the Cybersecurity Maturity Model Certification (CMMC) program. The…
Read More →
On October 16, 2024, the New York Department of Financial Services (DFS) issued an Industry Letter to regulated entities entitled…
Read More →
Part 1 – On July 17, 2024, the U.S. Patent and Trademark Office (the Office) released new guidance on subject…
Read More →
On October 16, 2024, the New York Department of Financial Services (“NYDFS”) issued an industry letter covering Cybersecurity Risks Arising…
Read More →
On October 8, 2024, Teva Pharmaceutical Industries Ltd. announced that the United States Food and Drug Administration (FDA) has accepted,…
Read More →
On October 10, 2024, the FDA approved Accord BioPharma’s Imuldosa™ (ustekinumab-srlf), the fifth biosimilar of Janssen / Johnson & Johnson’s Stelara®…
Read More →